SCHEMBL19634258

SCHEMBL19634258

COc1ccc(CN(Sc2cc(Cl)c(F)cc2F)c2cccc(F)n2)c(OC)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 2/20 0.38
SLC6A4 P31645 2/20 0.38
KCNH2 Q12809 2/20 0.38
KDM4E B2RXH2 3/20 0.35
KMT2A Q03164 4/20 0.34
MEN1 O00255 3/20 0.34
MAPT P10636 1/20 0.34
TSHR P16473 6/20 0.34
ALDH1A1 P00352 5/20 0.34
LMNA P02545 4/20 0.34
CYP1A2 P05177 4/20 0.34
CYP3A4 P08684 4/20 0.34
CYP2D6 P10635 4/20 0.34
CYP2C19 P33261 4/20 0.34
CLK4 Q9HAZ1 3/20 0.34
GLA P06280 1/20 0.34
HTT P42858 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
DHFR P00374 1/20 0.33
APLNR P35414 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19634018 0.86 MEN1 (0.39) HTR2ASLC6A4KCNH2KDM4EKMT2A
SCHEMBL20256738 0.86 CYP1A2 (0.39) KDM4EKMT2AMEN1MAPTTSHR
SCHEMBL20256542 0.86 CYP1A2 (0.38) KDM4EKMT2AMEN1MAPTTSHR
SCHEMBL19633951 0.85 KMT2A (0.36) HTR2ASLC6A4KCNH2KDM4EKMT2A
SCHEMBL19634254 0.83 KMT2A (0.37) HTR2ASLC6A4KCNH2KDM4EKMT2A
SCHEMBL21783444 0.83 KMT2A (0.37) HTR2ASLC6A4KCNH2KDM4EKMT2A
SCHEMBL20256741 0.82 KMT2A (0.35) KDM4EKMT2AMEN1MAPTTSHR
SCHEMBL20256934 0.82 CYP1A2 (0.38) HTR2ASLC6A4KCNH2KDM4EKMT2A
SCHEMBL20256415 0.82 HTR2A (0.38) HTR2ASLC6A4KCNH2KDM4EKMT2A
SCHEMBL20256744 0.82 GAA (0.38) HTR2ASLC6A4KCNH2KDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018106284-A1 BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2018-06-14 WO disclosed
WO-2017201468-A1 BENZENESULFONAMIDE COMPOUNDS AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2017-11-23 WO disclosed